This study is testing the safety and efficacy of an investigational treatment for asthma in comparison to already FDA approved QVAR® inhaler and placebo. The study medication being evaluated is a potential generic version of an already approved medication. If enrolled in the study, participants can expect to spend up to 6 weeks in the study, including an initial screening and baseline visit followed by scheduled clinic visits.
To pre-qualify for this study, you must:
Qualified participants, will receive:
Health insurance is not needed to participate.
A clinical research study tests the safety and efficacy of an investigational medicine or treatment in a population of volunteers. Every medical breakthrough goes through the clinical trial process, so participants like you play a very important role in advancing medicine for present and future generations.
Protecting the health and safety of people who take part in clinical trials is the highest priority for clinical researchers throughout the entire study process. All clinical trials follow strict federal guidelines on how volunteers must be treated.
You have the right to leave a clinical trial at any time, for any reason. If you decide to leave a trial, talk to your doctor first. You will want to know how leaving the trial might affect your health and what other treatment options may be available.